Test Center

My Recent Searches

  • No Recent Search.

My Tests Viewed

  • No Test Viewed.

Showing search results for "thyroid cancer" 21-30 of 83

  1. Lynch Syndrome: Laboratory Support of Diagnosis and Management

    Lynch syndrome, an autosomal dominant disease, is characterized by a high lifetime risk of cancers including colorectal cancer, other gastrointestinal cancers, and endometrial and ovarian cancer. Early diagnosis and ... More

  2. Alpha-fetoprotein, Tumor Marker

    This test is used to distinguish between seminomatous and nonseminomatous testicular germ cell cancer, as well as monitor therapy, and detect recurrence of nonseminomatous testicular germ cell cancer. The test also ... More

  3. Colorectal Cancer Mutation Panel (KRAS, PIK3CA, BRAF, NRAS)

    Summarizes information relating to this test including clinical use and background, specimen requirements, methodology, test interpretation, and peer-reviewed references.... More

  4. CA 27.29

    This Test Summary provides a brief overview of this test including guidelines-based clinical use, clinical background, individuals suitable for testing, methodology, test interpretation, and specimen requirements.... More

  5. ColoVantage (methylated Septin 9)

    Provides a brief overview of this test including clinical use and background, methodology, test interpretation, and specimen requirements.... More

  6. CA 15-3

    This Test Summary provides a brief overview of this test including guidelines-based clinical use, clinical background, individuals suitable for testing, methodology, test interpretation, and specimen requirements.... More

  7. Prostate Cancer: Laboratory Support for Screening, Diagnosis, and Management

    Provides information relating to prostate cancer including clinical background, individuals suitable for testing, available tests and methodologies, test selection and interpretation, and peer-reviewed references.... More

  8. BRCAvantage, Comprehensive

    This test is used to assess risk of hereditary breast and ovarian cancer syndrome and other BRCA1- and BRCA2-associated hereditary cancers.... More

  9. PD-L1 Lung (Pembrolizumab), IHC

    This test is used to identify patients with non-small-cell lung cancer who are eligible for treatment with pembrolizumab.... More

  10. PD-L1 Lung (Nivolumab), IHC

    This test is used to identify patients with advanced nonsquamous, non-small-cell lung cancer who may have enhanced survival following treatment with nivolumab.... More

* The tests listed by specialist are a select group of tests offered. For a complete list of Quest Diagnostics tests, please refer to our Directory of Services.